MLXIPL and diabetes mellitus: ChREBP contributes to glucose-stimulated proliferation of β-cells (Zhang et al. 2015), and chronic overexpression of ChREBP results in loss of β-cell mass, β-cell apoptosis and diabetes (Katz et al. 2022), suggesting the critical role of ChREBP in the maintenance of β-cell mass.